# Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis

> **NCT02558543** · PHASE2 · TERMINATED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 40 (actual)

## Conditions studied

- Scleroderma, Systemic

## Interventions

- **DRUG:** Stromal Vascular fraction
- **DRUG:** Ringer lactate

## Key facts

- **NCT ID:** NCT02558543
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558543, "Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02558543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*